Innate and adaptive immunity plays a critical role in the defence of the lung and other mucosal surfaces exposed to micro-organisms. Anti-microbial peptides and proteins, cytokines and chemokines are important immune weapons as they build up the protective front for the respiratory tract. The notion that susceptibility to infectious diseases may be inherited is widely accepted and, as it is the failure to activate adaptive immunity that may allow infection to become established and progress toward invasion and dissemination, the recognition of specific gene defects affecting the ability of the immune system to overcome invading pathogens may shed light upon those mechanisms of immune regulation that are playing the most critical roles. The aim of the present review is to discuss some of the advances in infection immunogenetics that may lead to identify new strategies in the development of new anti-infectious and anti-inflammatory drugs. Copyright © 2005 S. Karger AG.

Bocchino, M., Marruchella, A., Saltini, C. (2005). Immunogenetics of severe respiratory infections: Models for the development of new therapeutic strategies, 72(5), 449-457 [10.1159/000087666].

Immunogenetics of severe respiratory infections: Models for the development of new therapeutic strategies

SALTINI, CESARE
2005-01-01

Abstract

Innate and adaptive immunity plays a critical role in the defence of the lung and other mucosal surfaces exposed to micro-organisms. Anti-microbial peptides and proteins, cytokines and chemokines are important immune weapons as they build up the protective front for the respiratory tract. The notion that susceptibility to infectious diseases may be inherited is widely accepted and, as it is the failure to activate adaptive immunity that may allow infection to become established and progress toward invasion and dissemination, the recognition of specific gene defects affecting the ability of the immune system to overcome invading pathogens may shed light upon those mechanisms of immune regulation that are playing the most critical roles. The aim of the present review is to discuss some of the advances in infection immunogenetics that may lead to identify new strategies in the development of new anti-infectious and anti-inflammatory drugs. Copyright © 2005 S. Karger AG.
2005
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIO
English
Con Impact Factor ISI
Animal models; Gene polymorphisms; Natural and acquired immunity; Pneumonia
acetylcysteine; anticoagulant agent; chemokine; cytokine; endotoxin antibody; ibuprofen; peptide; protein; protein inhibitor; recombinant interleukin 1 receptor blocking agent; tumor necrosis factor antibody; antiinflammatory activity; clinical trial; disease course; disease predisposition; disease severity; gene mutation; human; immune deficiency; immunogenetics; immunoregulation; infection risk; innate immunity; microbial activity; nonhuman; priority journal; respiratory system; respiratory tract infection; review; Cytokines; Genetic Predisposition to Disease; Humans; Immunity, Natural; Pneumonia; Respiratory Tract Infections; Sepsis
Bocchino, M., Marruchella, A., Saltini, C. (2005). Immunogenetics of severe respiratory infections: Models for the development of new therapeutic strategies, 72(5), 449-457 [10.1159/000087666].
Bocchino, M; Marruchella, A; Saltini, C
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/56946
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact